Sherbrooke Park Advisers »

Ligand Pharmaceuticals In shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $570k 5.7k 100.09

More positions owned by Sherbrooke Park Advisers

Gap (GAP)
Smartsheet Com Cl A (SMAR)
Lennar Corp Cl A (LEN)
Pure Storage Cl A (PSTG)
Micron Technology (MU)
Campbell Soup Company (CPB)
Ida (IDA)
AeroVironment (AVAV)
Pagerduty (PD)
Devon Energy Corporation (DVN)
Korn Ferry Com New (KFY)
Cardinal Health (CAH)
ConAgra Foods (CAG)
Amazon (AMZN)
Cirrus Logic (CRUS)

View all positions for Sherbrooke Park Advisers

Top funds holding Ligand Pharmaceuticals In

BlackRock
BlackRock
Vanguard Group
Henderson Group
Macquarie Group
Dimensional Fund Advisors
State Street Corporation
Stephens Investment Management Group
Congress Asset Management
Chicago Capital
St. Denis J. Villere & Co
Geode Capital Management
Rice Hall James & Associates
Ashford Capital Management
Impax Asset Management Group

View all funds holding Ligand Pharmaceuticals In